Market Overview

UPDATE: Tigress Initiates Coverage On Illumina

Share:
Related ILMN
Benzinga's Top Upgrades, Downgrades For March 20, 2017
15 Biggest Mid-Day Gainers For Monday

In a report released Friday, Tigress analyst Philip Van Deusen initiated coverage on Illumina (NASDAQ: ILMN) with a Buy rating.

Analysts at Tigress favor Illumina for reducing costs in its genomic health progress with its genetic testing, diagnosis and individualized treatment. Illumina's development of hardware will strengthen, influencing an increase to barriers to entry. Tigress holds high expectations for Illumina sequencing machines, growing 51 percent year over year and making a majority of the company's revenue.

Latest Ratings for ILMN

DateFirmActionFromTo
Mar 2017Leerink SwannUpgradesMarket PerformOutperform
Feb 2017Evercore ISI GroupUpgradesHoldBuy
Jan 2017Deutsche BankInitiates Coverage OnHold

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: Philip Van Deusen TigressInitiation Analyst Ratings

 

Related Articles (ILMN)

View Comments and Join the Discussion!